Clinical Trial

Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to identify independent risk factors for 30-day mortality in patients aged 80 and over who have undergone major abdominal surgery. While traditional risk scoring systems often focus on chronic disease burden, they may not fully capture the biological decline associated with aging. This research specifically focuses on the predictive value of "frailty" and "physiological reserve" in determining surgical outcomes for this "old-old" patient population. In this retrospective cohort study, data from approximately 200 patients treated between 2022 and 2025 will be analyzed. Frailty will be assessed using the Modified Frailty Index (mFI-5), and physiological reserve will be evaluated through preoperative laboratory markers such as albumin, creatinine, and lymphocyte counts. By determining how these factors influence postoperative mortality, the study aims to improve preoperative patient selection, enhance risk communication with families, and provide a basis for protective strategies like prehabilitation.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-05-01
notable Enrollment reduced: 200 -> 100 participants 2026-05-01
Trial Details
NCT Number NCT07440095
Lead Sponsor Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Conditions Frailty, Postoperative Complications, Aged, 80 and Over, Abdomen Cancer
Enrollment 100 participants
Start Date 2026-03-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-30